Intervention Review

Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities

  1. Alex Thomson1,*,
  2. Stefanos Maltezos1,
  3. Elena Paliokosta1,
  4. Kiriakos Xenitidis2

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 9 AUG 2007

DOI: 10.1002/14651858.CD007009.pub2


How to Cite

Thomson A, Maltezos S, Paliokosta E, Xenitidis K. Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007009. DOI: 10.1002/14651858.CD007009.pub2.

Author Information

  1. 1

    Kings College London, Institute of Psychiatry, Section of Brain Maturation (P050), London, UK

  2. 2

    Bethlem Royal Hospital, South London and Maudsley NHS Foundation Trust, Mental Impairment Evaluation and Treatment Services, Beckenham, Kent, UK

*Alex Thomson, Section of Brain Maturation (P050), Kings College London, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. alex.thomson@kcl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH